National trials for CCSVI treatment for MS patients to begin in November

Posted: Published on September 29th, 2012

This post was added by Dr Simmons

Brandon Sun - ONLINE EDITION

By: Staff Writer

28/09/2012 12:16 PM | Comments: 0

ADRIAN WYLD / THE CANADIAN PRESS Enlarge Image

Minister of Health Leona Aglukkaq

A national clinical trial to test a controversial treatment for multiple sclerosis has received the necessary medical and ethical approvals to proceed, federal Health Minister Leona Aglukkaq announced today.

Recruitment for participants will begin Nov. 1 in Vancouver and Montreal. Participants will also be sought in Winnipeg and Quebec City, once ethics approval is granted for these centres to join. That could occur later in November.

Altogether, 100 MS patients will take part in the first phase of the clinical trials.

Dr. Anthony Traboulsee, medical director of the UBC Hospital MS Clinic, and his collaborators received ethics approvals from institutions in British Columbia and Qubec to undertake the clinical trial for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in persons with multiple sclerosis (MS).

CCSVI is a term used to describe the problem with blood flow in neck veins. Some doctors believe it plays a role in causing MS.

Here is the original post:
National trials for CCSVI treatment for MS patients to begin in November

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.